In AD, neuron-derived BEVs routinely show elevated Aβ42 and phosphorylated tau (p-tau181), alongside reduced synaptic proteins such as synaptophysin, with additional increases in miR-21, miR-34a, and miR-125b, capturing neuroinflammatory and synaptic loss signals. This evidence concerns the gene MAPT and Alzheimer disease.